Abstract
Purpose
To address whether differential regulation of the renin-angiotensin-aldosterone system occurs in pre-eclampsia, we performed an analysis of the time course of circulating and urinary profiles of the vasoconstrictor (Ang II) and the vasodilator [Ang-(1–7)] peptides in normal pregnant (NP) and pre-eclamptic (PE) women.
Methods
Urine and plasma samples from 86 nulliparous women were collected prospectively; 67 subjects continued as NP and 19 developed PE. Subjects were enrolled prior to 12 weeks of gestation and plasma and spot urine samples were obtained throughout gestation. Control samples were obtained at 6 weeks postpartum (PP).
Results
Mean blood pressure (p < 0.001) was elevated at 31–37 weeks of gestation in PE subjects as compared with NP subjects. Plasma Ang I and Ang II levels were elevated in NP subjects as early as 16 weeks of gestation and maintained throughout gestation. In PE subjects both plasma Ang I and Ang II were elevated at 16–33 weeks as compared with PP levels. PE subjects showed reduced plasma Ang I and Ang II (at 35–37 weeks of gestation) compared with NP subjects. Plasma Ang-(1–7) was unchanged in both groups. All three urinary peptides increased throughout gestation in NP subjects. In PE subjects urinary Ang I was increased at 23–26 weeks and was maintained throughout gestation. Urinary Ang II was increased at 27–29 and 31–33 weeks of gestation. PE subjects had no change in urinary Ang-(1–7).
Conclusion
The activation of the RAS, particularly Ang II throughout normal gestation may contribute to the maintenance of vascular tone during normal pregnancy. However higher sensitivity to Ang II in pre-eclampsia may be potentiated by the higher circulating and urinary levels of Ang II, unopposed by local renal Ang-(1–7), and thus may contribute to the development of pre-eclampsia.
Similar content being viewed by others
References
ACOG, Practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 133(1), e1–e25 (2019)
B. Sibai, G. Dekker, M. Kupferminc, Pre-eclampsia. Lancet 365(9461), 785–799 (2005)
D.C. Merrill, M. Karoly, K. Chen, C.M. Ferrario, K.B. Brosnihan, Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 18, 239–245 (2002)
P. August, T. Lenz, K.L. Ales, M.L. Druzin, T.G. Edersheim, J.M. Hutson et al. Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am. J. Obstetr. Gynecol. 163, 1612–1621 (1990)
N.F. Gant, G.L. Daley, S. Chand, P.J. Whalley, P.C. MacDonald, A study of angiotensin II pressor response throughout primigravid pregnancy. J. Clin. Invest. 52, 2682–2689 (1973)
G. Valdes, A.M. Germain, J. Corthorn, C. Berrios, A.C. Foradori, C.M. Ferrario et al. Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation. Endocrine 16(2), 117–122 (2001)
K.B. Brosnihan, P. Li, C.M. Ferrario, Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 27(Part 2), 523–528 (1996)
G. Raffai, G. Khang, P.M. Vanhoutte, Angiotensin-(1-7) augments endothelium-dependent relaxations of porcine coronary arteries to bradykinin by inhibiting angiotensin-converting enzyme 1. J. Cardiovasc. Pharm. 63(5), 453–460 (2014)
N. Jaiswal, E.A. Tallant, R.K. Jaiswal, D.I. Diz, C.M. Ferrario, Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved. J. Pharm. Exp. Ther. 265, 664–673 (1993)
S.Y. Osei, R.S. Ahima, R.K. Minkes, J.P. Weaver, M.C. Khosla, P.J. Kadowitz, Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur. J. Pharm. 234, 35–42 (1993)
National High Blood Pressure Education Program NHPEP. Working group report on high blood pressure in pregnancy 1991 Report No.: 91–3029 (1991)
D.S. Boeldt, I.M. Bird, Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia. J. Endocrinol. 232(1), R27–R44 (2017)
P. von Dadelszen, L.A. Magee, J.M. Roberts, Subclassification of preeclampsia. Hypertens. Pregnancy 22(2), 143–148 (2003)
K. Kohara, Y. Tabuchi, P. Senanayake, K.B. Brosnihan, C.M. Ferrario, Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures. Peptides 12, 1135–1141 (1991)
P.D. Senanayake, A. Moriguchi, H. Kumagai, D. Ganten, C.M. Ferrario, K.B. Brosnihan, Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides 15, 919–926 (1994)
P.S. Senanayake, R.R. Smeby, A.S. Martins, A. Moriguchi, H. Kumagai, D. Ganten et al. Adrenal, kidney, and heart angiotensins in female murine Ren-2 transfected hypertensive rats. Peptides 19(10), 1685–1694 (1998)
S.D. Sykes, K.G. Pringle, A. Zhou, G.A. Dekker, C.T. Roberts, E.R. Lumbers, Fetal sex and the circulating renin-angiotensin system during early gestation in women who later develop preeclampsia or gestational hypertension. J. Hum. Hypertens. 28(2), 133–139 (2014)
B. Langer, M. Grima, C. Coquard, A.M. Bader, G. Schlaeder, J.L. Imbs, Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia. Obstet. Gynecol. 91(2), 196–202 (1998)
M.A. Brown, J. Wang, J.A. Whitworth, The renin-angiotensin-aldosterone system in pre-eclampsia. Clin. Exp. Hypertension 19(5–6), 713–726 (1997).
E.P. Velloso, R. Vieira, A.C. Cabral, E. Kalapothakis, R.A. Santos, Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype. Braz. J. Med. Biol. Res. 40(4), 583–590 (2007)
Y.P. Chen, Y.P. Lu, J. Li, Z.W. Liu, W.J. Chen, X.J. Liang et al. Fetal and maternal angiotensin (1-7) are associated with preterm birth. J. Hypertens. 32(9), 1833–1841 (2014)
G. Wallukat, V. Homuth, T. Fischer, C. Lindschau, B. Horstkamp, A. Jupner et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J. Clin. Investig. 103(7), 945–952 (1999)
E.R. Lumbers, K.G. Pringle, Roles of the circulating renin-angiotensin-aldosterone system in human pregnancy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 306(2), R91–R101 (2014)
K.D. Burns, Y. Lytvyn, F.H. Mahmud, D. Daneman, L. Deda, D.B. Dunger et al. The relationship between urinary renin-angiotensin system markers, renal function, and blood pressure in adolescents with type 1 diabetes. Am. J. Physiol. Ren. Physiol. 312(2), F335–F342 (2017)
K.G. Pringle, S.D. Sykes, E.R. Lumbers, Circulating and intrarenal renin-angiotensin systems in healthy men and nonpregnant women. Physiol. Rep. 3(10), e2586 e1–10 (2015)
H. Kobori, A. Nishiyama, L.M. Harrison-Bernard, L.G. Navar, Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension. Hypertension 41(1), 42–49 (2003)
E.R. Lumbers, S.L. Skinner, The occurrence and assay of renin in human urine. Aust. J. Exp. Biol. Med Sci. 47(2), 251–262 (1969)
J. Wysocki, A. Goodling, M. Burgaya, K. Whitlock, J. Ruzinski, D. Batlle et al. Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease. Am. J. Physiol. Ren. Physiol. 313(2), F487–F494 (2017)
C.M. Ferrario, N. Martell, C. Yunis, J.M. Flack, M.C. Chappell, K.B. Brosnihan et al. Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects. Am. J. Hypertens. 11, 137–146 (1998)
J. Joyner, L.A. Neves, K. Stovall, C.M. Ferrario, K.B. Brosnihan, Angiotensin-(1-7) serves as an aquaretic by increasing water intake and diuresis in association with downregulation of aquaporin-1 during pregnancy in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294(3), R1073–R1080 (2008)
L.M. Yamaleyeva, D.C. Merrill, T.J. Ebert, T.L. Smith, H.L. Mertz, K.B. Brosnihan, Hemodynamic responses to angiotensin-(1-7) in women in their third trimester of pregnancy. Hypertens Pregnancy 33, 375–388 (2014)
G. Valdes, P. Kaufmann, J. Corthorn, R. Erices, K.B. Brosnihan, J. Joyner-Grantham, Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod. Biol. Endocrinol. 7(1), 27–79 (2009)
E.R. Lumbers, Peripheral vascular reactivity to angiotensin and noradrenaline in pregnant and non-pregnant women. Aust. J. Exp. Biol. Med Sci. 48(5), 493–500 (1970)
L. Malha, C.P. Sison, G. Helseth, J.E. Sealey, P. August, Renin-angiotensin-aldosterone profiles in pregnant women with chronic hypertension. Hypertension 72(2), 417–424 (2018)
Acknowledgements
The authors gratefully acknowledge support in part provided by R. Odell Farley Research Fund in Hypertension and Vascular Disease. We acknowledge the contributions of the Biomarker Analytical Core of the Hypertension and Vascular Research Center.
Funding
This study was funded by NIH/NHLBI HL070130 (David C. Merrill, PI) and NICHD 42631 (K. Bridget Brosnihan, PI).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Brosnihan, K.B., Merrill, D.C., Yamaleyeva, L.M. et al. Longitudinal study of angiotensin peptides in normal and pre-eclamptic pregnancy. Endocrine 69, 410–419 (2020). https://doi.org/10.1007/s12020-020-02296-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-020-02296-3